PILERI, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 5.218
NA - Nord America 4.950
EU - Europa 3.443
AF - Africa 291
SA - Sud America 268
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 14.186
Nazione #
US - Stati Uniti d'America 4.880
SG - Singapore 1.534
VN - Vietnam 1.321
CN - Cina 1.296
GB - Regno Unito 720
IT - Italia 696
SE - Svezia 471
DE - Germania 464
HK - Hong Kong 459
IN - India 258
RU - Federazione Russa 202
BR - Brasile 191
FR - Francia 141
KR - Corea 136
IE - Irlanda 130
UA - Ucraina 125
NL - Olanda 115
CI - Costa d'Avorio 93
BG - Bulgaria 70
ZA - Sudafrica 65
FI - Finlandia 63
JP - Giappone 56
TG - Togo 54
EE - Estonia 50
CH - Svizzera 47
CA - Canada 38
AR - Argentina 35
ID - Indonesia 34
AT - Austria 32
SC - Seychelles 29
JO - Giordania 26
MX - Messico 26
NG - Nigeria 26
PL - Polonia 25
ES - Italia 18
IR - Iran 18
EC - Ecuador 14
TR - Turchia 14
AU - Australia 12
BE - Belgio 12
BD - Bangladesh 11
HR - Croazia 11
CO - Colombia 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
EG - Egitto 8
LT - Lituania 8
LB - Libano 7
DK - Danimarca 6
RO - Romania 6
CZ - Repubblica Ceca 5
TH - Thailandia 5
UY - Uruguay 5
IL - Israele 4
RS - Serbia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MD - Moldavia 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
VE - Venezuela 3
BY - Bielorussia 2
CG - Congo 2
KE - Kenya 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 14.186
Città #
Singapore 1.002
Southend 619
Fairfield 548
Ashburn 518
Hong Kong 454
Chandler 450
Ho Chi Minh City 338
Hefei 322
Hanoi 263
Santa Clara 260
Houston 219
Woodbridge 219
Seattle 217
Wilmington 217
Beijing 212
Princeton 185
Cambridge 157
Bologna 152
Dong Ket 140
Seoul 134
Dublin 130
Boardman 124
Ann Arbor 102
Abidjan 93
Los Angeles 76
Dallas 70
Sofia 65
Westminster 65
Nanjing 63
New York 61
Jacksonville 60
Redmond 56
Berlin 54
Lomé 54
Redondo Beach 50
Tokyo 48
Milan 45
Helsinki 44
Padova 43
Saint Petersburg 41
Buffalo 40
Bremen 39
Jinan 38
San Diego 38
Haiphong 33
Turin 33
Munich 32
Redwood City 30
Shenyang 29
Bengaluru 27
Amman 26
Changsha 26
Abeokuta 25
Bern 25
Thái Nguyên 25
Vienna 25
Da Nang 24
London 24
Rome 23
São Paulo 23
Tianjin 23
Hebei 22
Quận Bình Thạnh 22
Frankfurt am Main 21
Jakarta 21
Nanchang 21
Hangzhou 20
Zhengzhou 20
Can Tho 19
Falls Church 19
Ha Long 19
Vũng Tàu 19
Biên Hòa 18
Chicago 18
Delhi 17
Des Moines 17
Florence 17
Mülheim 17
Guangzhou 16
Norwalk 16
Quận Sáu 16
Warsaw 16
Nuremberg 15
Olalla 15
Yubileyny 15
Dearborn 14
Haikou 14
Shanghai 14
Bắc Ninh 13
Hải Dương 13
Ninh Bình 13
San Jose 13
Bắc Giang 12
Hyderabad 12
Jiaxing 12
Mexico City 11
Taiyuan 11
Brooklyn 10
Brussels 10
Chengdu 10
Totale 9.196
Nome #
Merkel cell carcinoma: a prompt diagnosis to increase survival 626
Napkin psoriasis and the risk of later psoriasis development: A single-centre retrospective study 326
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 231
Management of malignant cutaneous wounds in oncologic patients 215
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 200
Primary cutaneous large B-cell lymphoma, leg type, localized on the dorsum 198
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 188
Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. 183
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 181
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 169
Anaplastic Large Cell Lymphoma: a critical reappraisal 166
Atopic Dermatitis and the Atopic March: What Is New? 166
Herpes zoster in COVID-19-positive patients 166
Annular lesions located on the right forearm. 165
A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine 164
Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma 163
Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). 161
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 161
Photodynamic therapy: An option in mycosis fungoides 159
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 157
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 156
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 155
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 154
Mycosis fungoides following pityriasis lichenoides: An exceptional event or a potential evolution? 151
Rosacea-like tinea incognito 150
Atypical piloleiomyoma of the face presenting with central ulceration 149
Large granular lymphocytic leukaemia mimicking ulcer of the lower limb 144
Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis 140
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 138
Leukemia cutis in a Ph+ ALL patient treated with ponatinib 137
An asymptomatic plaque on the chest: A quiz 134
Cutaneous adverse-events in patients treated with Ibrutinib 134
Alopecia areata-like mycosis fungoides: Lions for lambs 133
Bosentan and Extracorporeal Photochemotherapy in Eosinophilic Fasciitis: Synergistic Action or Fortuitous Coincidence? 133
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 132
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 132
Brownish asymptomatic lesions on the arms and legs 132
Vemurafenib mucosal side-effect. 130
Granulomatous tattoo reaction in a nivolumab-treated patient 130
Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region 128
Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. 127
Chilblain lesions after COVID-19 mRNA vaccine 126
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 125
Plaques and tumors in a patient with refractory Sézary syndrome treated with mogamulizumab 125
Persistent agmination of lymphomatoid papulosis: an ongoing debate. 125
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 125
The karma of Kikuchi's disease. 124
Idiopathic follicular mucinosis: Can dermoscopy be helpful? 123
Dermatofibrosarcoma protuberans secondary to a decorative tattoo: An Isotattootopic Response? 123
Primary cutaneous small/medium-sized pleomorphic T-cell lymphoproliferative disorder shows a common vascular pattern at dermoscopy 122
Multisystemic and Multiresistant Langerhans Cell Histiocytosis: A Case Treated With BRAF Inhibitor 121
Plaques und Tumoren unter der Therapie mit Mogamulizumab bei einer Patientin mit refraktärem Sézary-Syndrom 121
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 119
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 118
Multiple familial trichodiscomas. 118
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients 118
Papular mycosis fungoides: a new casa expanding the spectrum of phenotypic and clinical findings 116
Extramedullary metastatic plasmacytoma in a multiple myeloma patient 116
Erythematous induration of the chest 115
Peripheral T-cell lymphoma. 114
Indolent lymphoma: the pathologist's viewpoint 114
New therapies and old side-effects in mycosis fungoides treatment: brentuximab vedotin-induced alopecia 114
Pityriasis lichenoides getriggert durch eine Masern‐Mumps‐Röteln‐Impfung 114
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 114
Nb‐UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single‐center cross‐sectional study 112
Erythroderma and non-Hodgkin T-cell lymphoma: what else, apart from Mycosis Fungoides and Sézary syndrome? 112
A large mass and erythematous-violaceous plaques - Ein großer tumor und livid-erythematöse plaques 112
Newly-discovered neural features expand the pathobiological knowledge of blastic plasmacytoid dendritic cell neoplasm 112
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis 111
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 110
Squamous cell carcinoma developed after ingenol mebutate therapy: A possible consequence of the treatment? 110
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model 110
Lymphoma classification: the quiet after the storm. 109
Lymphoma classification: Past, present and future 107
Primary cutaneous peripheral T-cell lymphoma not otherwise specified a rare and aggressive lymphoma 106
TOX Expression in Mycosis Fungoides and Sezary Syndrome 104
Verrucous mycosis fungoides. 103
Multiple Eruptive Sebaceous Hyperplasia Secondary to Muir-Torre Syndrome Treated With Fractional Carbon Dioxide Laser Resurfacing Technique: A Case Report 100
Unilateral eosinophilic fasciitis (Shulman syndrome) with excellent response to combined treatment with methotrexate therapy and compression brace 100
Folliculotropic mycosis fungoides of the face successfully treated combining CO2 laser and conventional photodynamic therapy (c-PDT) 99
The role of myeloid derived suppressor cells in mycosis fungoides 98
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report 98
Mycosis fungoides: disease evolution of the "lion queen" revisited. 96
Sézary Syndrome without erythroderma featuring a CD30+ progression 93
Is Dermoscopy Useful for the Diagnosis of Pseudolymphomas? 91
Epcoritamab injection site skin eruption: a frequent yet unharmful effect due to a local delayed reaction mechanism 88
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 88
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 87
Pityriasis lichenoides triggered by measles-mumps-rubella vaccine injection 86
Erosive pustular dermatosis of the leg: An uncommon entity? 85
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 85
Unilesional folliculotropic mycosis fungoides: a true rarity in the clinico-pathologic spectrum? 78
Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides 78
Dimethyl fumarate: a case of improvement of alcoholic steatohepatitis in an elderly psoriatic patient 75
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 72
Micosi fungoide: nuovi orizzonti dal microambiente? 71
Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP) 69
Prognostic significance of Bcl-2 expression in primary cutaneous B-cell lymphoma: a reappraisal 69
null 68
Cutaneous involvement in multiple myeloma. A rare entity 68
Totale 13.174
Categoria #
all - tutte 42.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021728 0 0 0 0 0 0 44 50 128 67 50 389
2021/20221.598 83 45 99 137 148 98 27 137 88 137 337 262
2022/20231.880 208 264 107 247 140 152 69 144 265 63 154 67
2023/2024593 39 109 33 48 35 109 80 44 10 36 18 32
2024/20252.752 108 363 220 213 438 103 240 100 56 176 168 567
2025/20264.155 851 1.107 583 492 728 391 3 0 0 0 0 0
Totale 14.551